Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement
Sponsor: Beth Israel Deaconess Medical Center
Summary
The purpose of this study is to determine whether administration of a pectoral nerve blocks (Pecs I and II) with 0.25% bupivacaine are more effective as compared to placebo to provide analgesia for cardiac implantable electronic device (CIED) placement in cardiac electrophysiology lab
Official title: Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement: A Pilot Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
62
Start Date
2022-11-17
Completion Date
2025-03
Last Updated
2024-10-01
Healthy Volunteers
Yes
Conditions
Interventions
0.25% Bupivacaine
The intervention group/ bupivacaine group will receive up to 25 ml of 0.25% bupivacaine hydrochloride for the Pecs block in comparison to the control group that would receive 0.9% normal saline
Locations (1)
BIDMC
Boston, Massachusetts, United States